Stock Analysts

Snapchat’s Parent Company to Reportedly File for IPO Soon

Snap Inc, the parent company of popular social network Snapchat, will be filing for its IPO next week, as per several media reports. The reports further add that Snap Inc.’s financial strategy will become public once the registration document it filed with the Securities and Exchange Commission (SEC) in 2016 is revealed. In November last year , the firm filed for an IPO with the SEC under the U.S. […]

Technicals

Should You Buy MasterCard (MA) Ahead of Earnings?

Investors are always looking for stocks that are poised to beat at earnings season and MasterCard Inc MA may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because MasterCard is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat […]

Technicals

3 Reasons Why II-VI Inc. (IIVI) is a Great Momentum Stock

Many investors like to look for momentum in stocks, but this can be very tough to define. There is great debate regarding which metrics are the best to focus on in this regard, and which are not really quality indicators of future performance. Fortunately, with our new style score system we have identified the key statistics to pay close attention to and thus which stocks might be the best for momentum investors in the near term […]

Technicals

Looking for a Growth Stock? Why It is Time to Focus on Citizens Financial (CFG)

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, these can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses. One such company that might be well-positioned for future earnings growth is Citizens Financial Group, Inc. […]

Stock Analysts

Abiomed (ABMD) Beats Earnings & Revenue Estimates in Q3

Danvers, MA-based Abiomed Inc. ABMD , a leading developer, manufacturer and marketer of medical products, reported third-quarter fiscal 2017 earnings of 34 cents per share, which surpassed the Zacks Consensus Estimate by 5 cents and surged 47.8% from the year-ago quarter. Notably, Abiomed’s streak of positive earnings surprises is noteworthy, which accounts for an average beat of 16.4% over the last four quarters. […]